Marty T Lehto
- Current and future molecular diagnostics for prion diseasesMarty T Lehto
Amorfix Life Sciences, 3080 Yonge Street, Suite 6020, Toronto, M4N 3N1, Canada
Expert Rev Mol Diagn 6:597-611. 2006..This review highlights some of the conventional and disruptive technologies developed to respond to this challenge...
- A prion protein epitope selective for the pathologically misfolded conformationEustache Paramithiotis
Caprion Pharmaceuticals Inc, 7150 Alexander Fleming, St Laurent, Quebec H4S 2C8, Canada
Nat Med 9:893-9. 2003..Conformation-selective exposure of Tyr-Tyr-Arg provides a probe for the distribution and structure of pathologically misfolded prion protein, and may lead to new diagnostics and therapeutics for prion diseases...